4.5 Article

The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53

Journal

MOLECULAR CANCER RESEARCH
Volume 15, Issue 6, Pages 735-743

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-17-0019

Keywords

-

Funding

  1. Intramural Research Program of the NIH [NIEHS Z01-ES065079]

Ask authors/readers for more resources

The APOBEC3 (A3) family of proteins are DNA cytidine deaminases that act as sentinels in the innateimmune response against retroviral infections and are responsive to IFN. Recently, a few A3 genes were identified as potent enzymatic sources of mutations in several human cancers. Using human cancer cells and lymphocytes, we show that under stress conditions and immune challenges, all A3 genes are direct transcriptional targets of the tumor suppressor p53. Although the expression of most A3 genes (including A3C and A3H) was stimulated by the activation of p53, treatment with the DNA-damaging agent doxorubicin or the p53 stabilizer Nutlin led to repression of the A3B gene. Furthermore, p53 could enhance IFN type-I induction of A3 genes. Interestingly, overexpression of a group of tumor-associated p53 mutants in TP53-null cancer cells promoted A3B expression. These findings establish that the guardian of the genome role ascribed to p53 also extends to a unique component of theimmune system, the A3 genes, thereby integrating human immune and chromosomal stress responses into an A3/p53 immune axis. (C) 2017 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available